ArticleAmerican journal of translational research2023

The suppression of ATR/Chk1 pathway by Elimusertib ATR inhibitor in triple negative breast cancer cells.

Ayten Haciefendi et al.PubMed ↗Full text ↗

No numbers read from the abstract.